Sarnacki S, Nakai H, Calise D, Azuma T, Brousse N, Révillon Y, Cerf-Bensussan N
Service de Chirurgie Pédiatrique, Faculté Necker Infants-Malades, 156, rue de Vaugirard, 75730 Paris Cedex 15, France.
Gut. 1998 Dec;43(6):849-55. doi: 10.1136/gut.43.6.849.
In a previous study, it was shown that a spontaneously tolerated DA (RT1a) liver allograft in a PVG (RT1c) recipient was able to induce tolerance of a DA small bowel graft performed 17 days later in spite of infiltration of the intestinal grafts by mononuclear cells.
To compare the phenotype of graft infiltrating cells in rejecting and tolerated small bowel grafts in order to elucidate the mechanism(s) which block the graft infiltrating cells from mediating rejection.
Multiparameter immunofluorescence was used to compare the phenotype and state of activation of donor and recipient cells isolated from intestinal grafts rejected or tolerated after liver transplantation.
Three differences were found. Firstly, there was a more rapid replacement of lamina propria (LP) cells by recipient lymphocytes in tolerated than in rejected grafts. Secondly, the proportion of LP recipient CD8alphabeta+ lymphocytes bearing the high affinity receptor for interleukin 2 was significantly less in tolerated grafts (1.1%, range 0-2%) than in rejected grafts (21.3%, range 9-26%). Finally, tolerated grafts contained significantly less NK lymphocytes (NKR-P1+) and macrophages than rejected intestinal allografts.
These observations make it possible to delineate clear cut differences in the phenotype of cells infiltrating rejecting versus tolerated grafts. Furthermore, the data suggest that liver transplantation induces tolerance of intestinal grafts by hampering the activation of recipient TcRalphabeta+ CD8alphabeta+ T cells and subsequently the recruitment of non-specific effector cells.
在之前的一项研究中,结果显示,在PVG(RT1c)受体中自发耐受的DA(RT1a)肝脏同种异体移植物,尽管肠道移植物有单核细胞浸润,但仍能够诱导17天后进行的DA小肠移植物产生耐受。
比较排斥和耐受的小肠移植物中移植物浸润细胞的表型,以阐明阻止移植物浸润细胞介导排斥反应的机制。
采用多参数免疫荧光法比较肝移植后排斥或耐受的肠道移植物中分离出的供体和受体细胞的表型及活化状态。
发现了三个差异。首先,与排斥的移植物相比,在耐受的移植物中,固有层(LP)细胞被受体淋巴细胞更快地替代。其次,在耐受的移植物中,携带白细胞介素2高亲和力受体的LP受体CD8αβ +淋巴细胞的比例(1.1%,范围0 - 2%)显著低于排斥的移植物(21.3%,范围9 - 26%)。最后,与排斥的小肠同种异体移植物相比,耐受的移植物中NK淋巴细胞(NKR - P1 +)和巨噬细胞明显更少。
这些观察结果使得能够明确区分排斥与耐受移植物中浸润细胞的表型差异。此外,数据表明肝移植通过阻碍受体TcRαβ + CD8αβ + T细胞的活化以及随后非特异性效应细胞的募集来诱导肠道移植物的耐受。